• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【药物名称】RB-360-II

【化学名称】[3(R)-(1H-Indol-3-ylmethyl)-3-methyl-2,5-dioxo-1,3-diazacyclotridec-13(S)-ylcarbonyl]-L-aspartyl-L-phenylalaninamide

【CA登记号】187454-95-1

【 分 子 式 】C35H44N6O7

【 分 子 量 】660.77693

【开发单位】INSERM (Originator)

【药理作用】PHARMACOLOGICAL TOOLS, CCK2 (CCKB/Gastrin) Agonists

合成路线1

8-Bromooctanoic acid (I) was treated with 2-methylpropene (II) in the presence of sulfuric acid to afford tert-butyl ester (III). Alkylation of the benzylidene derivative of glycine methyl ester (IV) with bromide (III) using lithium diisopropylamide (LDA) and hexamethylphosphoramide (HMPA) in THF at -78 C, followed by imine hydrolysis with aqueous citric acid provided the racemic aminoester (V). This was condensed with Boc-a-methyl(R)tryptophan (VI) using (benzotriazol-1-yloxy) tris(dimethylamino)phosphonium hexafluorophosphate (BOP) as the coupling reagent, in the presence of diisopropylethylamine (DIEA) to give the protected dipeptide (VII) as a diastereomeric mixture, and further treatment with trifluoroacetic acid in dichloromethane and anisole removed both tert-butyl groups. The resulting linear compound (VIII) was cyclized by treatment with BOP and NaHCO3 in DMF to give (IX), which was then hydrolyzed with NaOH to afford acid (X). Coupling with the dipeptide Asp(OBzl)PheNH2 (XI) yielded (XII), and the obtained benzyl ester was finally deprotected by catalytic hydrogenolysis to provide the target compound, after separation of isomers by semipreparative HPLC.

1 Blommaert, A.G.S.; et al.; Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor. J Med Chem 1997, 40, 5, 647-658.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18016 8-Bromooctanoic acid 17696-11-6 C8H15BrO2 详情 详情
(II) 15926 2-methyl-1-propene; isobutylene 115-11-7 C4H8 详情 详情
(III) 18017 tert-butyl 8-bromooctanoate C12H23BrO2 详情 详情
(IV) 18018 methyl 2-[[(E)-benzylidene]amino]acetate C10H11NO2 详情 详情
(V) 18019 10-(tert-butyl) 1-methyl 2-aminodecanedioate C15H29NO4 详情 详情
(VI) 18020 (2S)-2-[(tert-butoxycarbonyl)amino]-3-(1H-indol-3-yl)-2-methylpropionic acid C17H22N2O4 详情 详情
(VII) 18021 10-(tert-butyl) 1-methyl 2-[[(2R)-2-[(tert-butoxycarbonyl)amino]-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]decanedioate C32H49N3O7 详情 详情
(VIII) 18022 9-[[(2R)-2-amino-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-10-methoxy-10-oxodecanoic acid C23H33N3O5 详情 详情
(IX) 18023 methyl (2R)-2-(1H-indol-3-ylmethyl)-2-methyl-3,13-dioxo-1,4-diazacyclotridecane-5-carboxylate C23H31N3O4 详情 详情
(X) 18024 (2R)-2-(1H-indol-3-ylmethyl)-2-methyl-3,13-dioxo-1,4-diazacyclotridecane-5-carboxylic acid C22H29N3O4 详情 详情
(XI) 18025 benzyl (3S)-3-amino-4-[[(1S)-2-amino-1-benzyl-2-oxoethyl]amino]-4-oxobutanoate C20H23N3O4 详情 详情
(XII) 18026 benzyl (3S)-4-[[(1S)-2-amino-1-benzyl-2-oxoethyl]amino]-3-([[(2R)-2-(1H-indol-3-ylmethyl)-2-methyl-3,13-dioxo-1,4-diazacyclotridecan-5-yl]carbonyl]amino)-4-oxobutanoate C42H50N6O7 详情 详情
Extended Information